Lithuania – Antineoplastic agents – Monoclonal antibodies for the treatment of metastatic colon or rectal cancer (Cetuximab and/or Panitumumab)
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
The procuring organization intends to purchase monoclonal antibodies for the treatment of metastatic colon or rectal cancer (Cetuximab and/or Panitumumab) (hereinafter referred to as medicinal product/product). The requirements for the procurement object are set out in SS Appendix 2 "Technical specification".
Related Procurement Opportunities
Similar tenders in Services